ZIMBABWE ROLLS OUT LONG-ACTING HIV PREVENTION DRUG LENACAPAVIR
Why in the News?
- Public Health Initiative: Zimbabwe has launched rollout of long-acting injectable HIV prevention drug lenacapavir.
- Global First Mover: It is among the first countries offering a twice-yearly injectable HIV preventive treatment
LENACAPAVIR AND HIV PREVENTION STRATEGY
- Long-Acting Protection: Lenacapavir provides six months’ HIV prevention through a biannual injectable regimen, improving adherence compared to daily pills.
- Target Population: Initial phase targets 46,500 high-risk individuals, including young women and pregnant or breastfeeding mothers.
- Free Provision: Drug is offered free to vulnerable groups, ensuring equitable access to preventive healthcare services.
- Pharmaceutical Development: The medicine is developed by Gilead Sciences, highlighting role of private sector innovation in global health.
- Global Partnerships: Rollout supported through PEPFAR and the Global Fund, demonstrating multilateral cooperation in disease control.
PUBLIC HEALTH AND POLICY IMPLICATIONS
- Infection Control: Long-acting prophylaxis could significantly reduce new HIV infections, particularly in high-burden African nations.
- Adherence Advantage: Reduced dosing frequency addresses challenges of treatment compliance and stigma-related discontinuation.
- Maternal Health Linkage: Inclusion of pregnant and breastfeeding women strengthens mother-to-child transmission prevention efforts.
- Health Financing Model: International donor support reflects continued reliance on global health financing mechanisms.
- Equity Focus: Targeted prevention strategy aligns with principles of universal health coverage and vulnerable population protection.
HIV/AIDS PREVENTION AND GLOBAL HEALTH GOVERNANCE● HIV Burden: Sub-Saharan Africa remains disproportionately affected by HIV/AIDS, requiring sustained prevention strategies. ● Preventive Tools: Pre-exposure prophylaxis (PrEP) and long-acting injectables complement antiretroviral therapy frameworks. ● Global Institutions: Initiatives like PEPFAR and the Global Fund play central roles in combating infectious diseases. ● Public Health Strategy: Effective HIV control integrates prevention, testing, treatment, and community outreach mechanisms. ● UPSC Relevance: Topic relates to GS Paper II and III, covering health policy, international cooperation, and disease management strategies |